Longevity Investors & VC Firms in France
11 firms in this list, with a median first check of $540K. 2 of them lead rounds. Generated from verified public data and updated continuously.
Sofinnova Partners
ParisPre-Seed–Late Stage$540K – $27M
89 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
15 people
AdBio partners
ParisPre-Seed–Series A
3 people
Future Positive Capital
Pre-Seed–Series A
1 person
Catalio Capital Management, LP
New YorkSeed–Late Stage
36 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
42 people
HealthCap
StockholmSeed–Growth
34 people
Unruly Capital
LondonPre-Seed–Series A
3 people
Brookstreet Equity Partners
LondonPre-Seed–Growth
21 people
Aescap Life Sciences
AmsterdamSeed–Growth
14 people
Crista Galli Ventures
LondonPre-Seed–Series A
Frequently asked questions
- Who are the top longevity investors & vc firms in france?
- Top longevity investors & vc firms in france include Sofinnova Partners, Auriga Partners, AdBio partners, Future Positive Capital, Catalio Capital Management, LP, EQT Life Sciences, HealthCap, Unruly Capital — 11 firms in total meet the criteria.
- What is the typical first check among longevity investors & vc firms in france?
- The median first check among the 11 longevity investors & vc firms in france tracked here is $540K.
- How many longevity investors & vc firms in france lead rounds?
- 2 of the 11 longevity investors & vc firms in france tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.